Development and validation of a stability-indicating high performance liquid chromatographic (HPLC) assay for biperiden in bulk form and pharmaceutical dosage forms

Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences

Volumn 854, Issue 1-2, 2007, Pages 152-157

  Mohammadi, A ^a   Mehramizi, A ^b   Moghaddam, F Aghaee ^b   jabarian, L Erfani ^b   pourfarzib, M ^b,c   Kashani, H N ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Tehran Chemie Pharmaceutical Co   (Iran)

^c MINISTRY OF HEALTH AND MEDICAL EDUCATION   (Iran)

Author keywords

Biperiden; HPLC UV; Stability indicating

Indexed keywords

BIOASSAY; DRUG DOSAGE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHANOL; SEPARATION; ULTRAVIOLET RADIATION;

BIPERIDEN; PHARMACEUTICAL DOSAGE;

DRUG PRODUCTS;

BIPERIDEN; BUFFER; METHANOL; SODIUM DIHYDROGEN PHOSPHATE; SULFONIC ACID DERIVATIVE;

ACCURACY; ARTICLE; CONCENTRATION (PARAMETERS); DRUG DEGRADATION; DRUG DETERMINATION; DRUG DOSAGE FORM; DRUG SELECTIVITY; DRUG SENSITIVITY; DRUG STABILITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIQUID CHROMATOGRAPHY; PARTICLE SIZE; PH; PRIORITY JOURNAL; SPECTROPHOTOMETRY; TABLET FORMULATION; TITRIMETRY; ULTRAVIOLET RADIATION; VALIDATION PROCESS;

BIPERIDEN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; MUSCARINIC ANTAGONISTS; PHARMACEUTICAL PREPARATIONS; REFERENCE STANDARDS; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 34250783655     PISSN: 15700232     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jchromb.2007.04.016     Document Type: Article

References (21)

1. O'Neil M.J., Smith A., Heckelman P.E., and Budavari S. The Merck Index, An Encyclopedia of Chemicals, Drugs and Biologicals. 13th ed. (2001), Merck & Co. Inc., White House Station, New Jersey p. 201
2. ® (2001), American Society of Health - System Pharmacists, Inc., Bethesda p. 1177
3. Sweetman S.C. Martindale the Complete Drug Reference. 34th ed. (2005), Pharmaceutical Press, London p. 479
4. United States Pharmacopeia 28-NF 23. United States Pharmacopeial Convention, INC., Rockville, MD, 2005, p. 260.
5. Igarashi K., Yamamoto R., Shibata C., Furuki N., Kuwano S., Kasuya F., Fukui M., Iwahashi K., and Ameno K. Jpn. J. Forensic Toxicol. 17 (1999) 146
6. Gaillard Y., and Pepin G. J. Chromatogr. A 763 (1997) 149
7. Cápka V., and Xu Y. J. Chromatogr. Biomed. Appl. 762 (2001) 181
8. Hadidi K.A. Legal Med. 6 (2004) 233
9. Ottoila P., and Taskinen J. J. Chromatogr. Biomed. Appl. 226 (1981) 488
10. Eklund A., Jonsson J., and Schuberth J. J. Anal. Toxicol. 7 (1983) 24
11. Capacio B.R., Caro S.T., Smith J.R., and Byers C.E. Biomed. Chromatogr. 16 (2002) 47
12. Le Bris Th., and Brode E. Arzneimittel-Forschung/Drug Res. 35 (1985) 149
13. Ulrich S., Meyer F.P., and Bogerts B. J. Pharm. Biomed. Anal. 14 (1996) 441
14. Bargo E. J. Pharm. Sci. 68 (1979) 503
15. Mandrioli R., Musenga A., Lasaponara S.S., Saracino M.A., Fanali S., and Raggi M.A. Anal. Chim. Acta 560 (2006) 57
16. Stoll L., Fleckensein P., Riemann D., and Muller W.E. Res. Commun. Chem. Pathol. Pharmacol. 64 (1989) 59
17. European Pharmacopeia, fifth ed., Council of Europe, Strasbourg, 2005, p. 1101.
18. British Pharmacopeia, The Stationary Office, London, 2004, p. 260.
19. ICH, Stability Testing of New Drug Substances and Products (Q1AR2). International Conference on Harmonization, IFPMA, Geneva, 2003.
20. Moffat A.C., Osselten M.D., and Widdop B. Clarke's Analysis of Drugs and Poisons in Pharmaceuticals, Body Fluids and Postmortem Material. third ed. (2004), Pharmaceutical Press, London p. 701
21. ICH Draft Guidelines on Validation of Analytical procedures: Definitions and Terminology, Federal Register, vol. 60, IFPMA, Switzerland, 1995.